Last reviewed · How we verify
PENBUTOLOL
At a glance
| Generic name | PENBUTOLOL |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1987 |
Approved indications
Common side effects
Key clinical trials
- N-of-1 for Beta-Blockers in Cardiac Amyloidosis (PHASE4)
- A Preliminary Study for INFORMED (PHASE4)
- Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF (PHASE4)
- Impact of Beta-blockers on Physical Function in HFpEF (PHASE4)
- ACEI or ARB and COVID-19 Severity and Mortality in US Veterans
- Coreg and HSRs-Updated Analysis
- Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |